Company Filing History:
2 out of 3,684 
1 out of 41 Years Active: 1992-1997
Title: The Innovative Contributions of Ronald L Berry
Introduction
Ronald L Berry is a notable inventor based in North Branford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor antibiotics. With a total of 3 patents to his name, Berry's work has had a meaningful impact on cancer treatment.
Latest Patents
Berry's latest patents include novel antitumor depsipeptides produced by Micromonospora strain 39500, ATCC 55011. These compounds have a specific structural formula that showcases their potential in cancer therapy. Another significant patent is for an antibiotic designated BMY-42448, which is produced by the fermentation of Micromonospora narashinoensis strain C39217-R109-7 (ATCC-53791). BMY-42448 has demonstrated both in vitro and in vivo antitumor activity, highlighting its importance in the fight against cancer.
Career Highlights
Throughout his career, Ronald L Berry has worked with prominent companies such as Bristol-Myers Squibb Company. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Berry has collaborated with notable coworkers, including Kin S Lam and Grace A Hesler. These partnerships have facilitated the advancement of his research and the successful development of his patents.
Conclusion
Ronald L Berry's innovative work in the field of antitumor antibiotics showcases his dedication to improving cancer treatment. His contributions through patents and collaborations have made a lasting impact on the pharmaceutical industry.